Fulgent Genetics, Inc. (FLGT) Operating margin 2016–2025
Fulgent Genetics, Inc. (FLGT) operating margin by fiscal year — reported operating income divided by reported revenue.
-28.2%FY2025 · since FY2016: 5.0% → -28.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -28.2% | -2.2 pp |
| FY2024 | -26.1% | +41.5 pp |
| FY2023 | -67.6% | -96.4 pp |
| FY2022 | 28.8% | -39.3 pp |
| FY2021 | 68.1% | -0.7 pp |
| FY2020 | 68.8% | +70.1 pp |
| FY2019 | -1.3% | +22.4 pp |
| FY2018 | -23.7% | -5.2 pp |
| FY2017 | -18.6% | -23.6 pp |
| FY2016 | 5.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice